Advertisement
UK markets closed
  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     
  • FTSE 250

    20,164.54
    +112.21 (+0.56%)
     
  • AIM

    771.53
    +3.42 (+0.45%)
     
  • GBP/EUR

    1.1652
    -0.0031 (-0.26%)
     
  • GBP/USD

    1.2546
    +0.0013 (+0.11%)
     
  • Bitcoin GBP

    50,842.24
    +1,774.32 (+3.62%)
     
  • CMC Crypto 200

    1,359.39
    +82.41 (+6.45%)
     
  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     
  • DOW

    38,675.68
    +450.02 (+1.18%)
     
  • CRUDE OIL

    77.99
    -0.96 (-1.22%)
     
  • GOLD FUTURES

    2,310.10
    +0.50 (+0.02%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • HANG SENG

    18,475.92
    +268.79 (+1.48%)
     
  • DAX

    18,001.60
    +105.10 (+0.59%)
     
  • CAC 40

    7,957.57
    +42.92 (+0.54%)
     

Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings

Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.

The earnings figure itself is key, but a beat or miss on the bottom line can sometimes be just as, if not more, important. Therefore, investors should consider paying close attention to these earnings surprises, as a big beat can help a stock climb even higher.

2 Stocks to Add to Your Watchlist

The Zacks Earnings ESP, or Expected Surprise Prediction, aims to find earnings surprises by focusing on the most recent analyst revisions. The basic premise is that if an analyst reevaluates their earnings estimate ahead of an earnings release, it means they likely have new information that could possibly be more accurate. The core of the ESP model is comparing the Most Accurate Estimate to the Zacks Consensus Estimate, where the resulting percentage difference between the two equals the Expected Surprise Prediction.

ADVERTISEMENT

The final step today is to look at a stock that meets our ESP qualifications. Cardinal Health (CAH) earns a Zacks Rank #3 10 days from its next quarterly earnings release on May 2, 2024, and its Most Accurate Estimate comes in at $1.98 a share.

CAH has an Earnings ESP figure of 1.11%, which, as explained above, is calculated by taking the percentage difference between the $1.98 Most Accurate Estimate and the Zacks Consensus Estimate of $1.95.

CAH is part of a big group of Medical stocks that boast a positive ESP, and investors may want to take a look at Guardant Health (GH) as well.

Slated to report earnings on May 9, 2024, Guardant Health holds a #3 (Hold) ranking on the Zacks Rank, and it's Most Accurate Estimate is -$0.66 a share 17 days from its next quarterly update.

For Guardant Health, the percentage difference between its Most Accurate Estimate and its Zacks Consensus Estimate of -$0.72 is 8.55%.

CAH and GH's positive ESP metrics may signal that a positive earnings surprise for both stocks is on the horizon.

Find Stocks to Buy or Sell Before They're Reported

Use the Zacks Earnings ESP Filter to turn up stocks with the highest probability of positively, or negatively, surprising to buy or sell before they're reported for profitable earnings season trading. Check it out here >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Cardinal Health, Inc. (CAH) : Free Stock Analysis Report

Guardant Health, Inc. (GH) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research